+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID07265921

Phase I Study to Evaluate Safety, Tolerability, and Anti-Tumor Effects of SIM0609 in Adults with Advanced or Metastatic Solid Tumors

Led by Jiangsu Simcere Pharmaceutical Co., Ltd. · Updated on 2025-12-05

232

Participants Needed

6

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of SIM0609 in adults with locally advanced or metastatic solid tumors. This phase I, open-label, multicenter trial aims to explore how SIM0609 behaves in the body and its potential effects on different types of advanced solid cancers. The study is sponsored by Jiangsu Simcere Pharmaceutical Co., Ltd. and focuses on adults who have failed standard treatments for their cancer. The study involves multiple dose levels of SIM0609 to identify the maximum tolerated dose through a dose escalation phase. Following this, dose expansion phases will test 1 to 3 dose levels to assess preliminary antitumor activity in specific tumor types including colorectal carcinoma, gastricgastroesophageal junction adenocarcinoma, pancreatic ductal adenocarcinoma, and other solid tumors. Participants receive SIM0609 injections with dosing cycles lasting 21 or 28 days. Participants will be closely monitored for dose-limiting toxicities by the end of the first treatment cycle, along with safety and response outcomes over a two-year period. Researchers will evaluate tumor response rates and collect data on tolerability and pharmacokinetics. Assessments include tumor measurements and safety evaluations. The total duration of follow-up for participants can extend up to two years to gather comprehensive information on treatment effects and side effects.

CONDITIONS

Brief Title

A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors

Research Team

J

Jinxiu Zhang

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here